Elutia Inc. Insider Trading

ELUT

⊜ Compare

Last 12 months

Insiders bought 211K on the open market and sold nothing.

Net open-market

+211K

11 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

6 / 0

executives and directors

Last open-market buy

Jan 2026

Jan 30, 2026

Get an email when ELUT's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jan 30	Guido J Neels Director	Bought	20,000	$1.04	21K	20%	Form 4
Jan 30	Kevin Rakin Director	Bought	70,000	$1.06	74K	1.4%	Form 4
Jan 28 – 29	Guido J Neels Director	Bought 2 parts	30,000	$1.06 average	32K	44%	Form 4
Dec 17, 2025	Highcape Partners GP II, LLC Large holder	Bought	50,000	$0.52	26K	1.0%	Form 4
Dec 17, 2025	David Colpman Director	Bought	12,500	$0.51	6K	67%	Form 4
Dec 17, 2025	Brigid Makes Director	Bought	25,000	$0.52	13K	1250%	Form 4
Dec 17, 2025	C Randal Mills President and CEO	Bought	3,000	$0.51	2K	0.8%	Form 4
Dec 17, 2025	Matthew Ferguson Chief Financial Officer	Bought	60,000	$0.53	32K	15%	Form 4
Dec 1, 2025 – Dec 2, 2025	Matthew Ferguson Chief Financial Officer	Bought 2 parts	10,000	$0.66 average	7K	2.7%	Form 4
Nov 24, 2025	C Randal Mills President and CEO	Bought	5,000	$0.60	3K	1.4%	Form 4
Nov 17, 2025	David Colpman Director	Bought	15,500	$0.74	11K	500%	Form 4
Nov 13, 2025	C Randal Mills President and CEO	Bought 3 parts	13,500	$0.75 average	10K	4.0%	Form 4
Feb 3, 2025	Highcape Capital, L.p. Large holder	Bought	420,000	$2.50	$1.05M	4.6%	Form 4
Feb 3, 2025	Highcape Partners, L.p. Large holder	Bought	420,000	$2.50	$1.05M	4.6%	Form 4

Jan 30
Guido J Neels
Director · bought 20,000 at $1.04
21K
20% of stake
Jan 30
Kevin Rakin
Director · bought 70,000 at $1.06
74K
1.4% of stake
Jan 28 – 29
Guido J Neels
Director · bought 30,000 at avg $1.06
32K
44% of stake
Dec 17, 2025
Highcape Partners GP II, LLC
Large holder · bought 50,000 at $0.52
26K
1.0% of stake
Dec 17, 2025
David Colpman
Director · bought 12,500 at $0.51
6K
67% of stake
Dec 17, 2025
Brigid Makes
Director · bought 25,000 at $0.52
13K
1250% of stake
Dec 17, 2025
C Randal Mills
President and CEO · bought 3,000 at $0.51
2K
0.8% of stake
Dec 17, 2025
Matthew Ferguson
Chief Financial Officer · bought 60,000 at $0.53
32K
15% of stake
Dec 1, 2025 – Dec 2, 2025
Matthew Ferguson
Chief Financial Officer · bought 10,000 at avg $0.66
7K
2.7% of stake
Nov 24, 2025
C Randal Mills
President and CEO · bought 5,000 at $0.60
3K
1.4% of stake
Nov 17, 2025
David Colpman
Director · bought 15,500 at $0.74
11K
500% of stake
Nov 13, 2025
C Randal Mills
President and CEO · bought 13,500 at avg $0.75
10K
4.0% of stake
Feb 3, 2025
Highcape Capital, L.p.
Large holder · bought 420,000 at $2.50
$1.05M
4.6% of stake
Feb 3, 2025
Highcape Partners, L.p.
Large holder · bought 420,000 at $2.50
$1.05M
4.6% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ELUT, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with ELUT

CompareIntrinsic value

RVMDRevolution Medicines Inc.

$199.21+2.56%10

SRZNSurrozen, Inc.

$31.65+5.08%10

LCTXLineage Cell Therapeutics Inc.

$1.03+1.98%10

CRSPCrispr Therapeutics AG

$51.78+3.57%40

ALECAlector Inc.

$2.28+11.22%10

RLAYRelay Therapeutics Inc.

$18.03+3.38%40

CRBUCaribou Biosciences, Inc.

$0.44-3.27%10

ACOGAlpha Cognition Inc.

$8.49+3.48%10

Spot a number that looks wrong? Check it in ELUT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ELUT

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.